Login / Signup

Effect of once-weekly dulaglutide on renal function in patients with chronic kidney disease.

Sungmin KimJung Nam AnYoung Rim SongSung Gyun KimHyung Seok LeeAJin ChoJwa-Kyung Kim
Published in: PloS one (2022)
The use of dulaglutide provided adequate glycemic control irrespective of CKD stage and was associated with a reduced decline in the eGFR in the CKD population.
Keyphrases
  • glycemic control
  • chronic kidney disease
  • type diabetes
  • blood glucose
  • small cell lung cancer
  • epidermal growth factor receptor
  • weight loss
  • tyrosine kinase